{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:57:36Z","timestamp":1790384256190,"version":"4.1.0"},"reference-count":191,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and\/or pregnancy morbidity in association with persistent antiphospholipid antibodies. The 16th International Congress on Antiphospholipid Antibodies Task Force on APS Treatment Trends reviewed the current status with regard to existing and novel treatment trends for APS, which is the focus of this Task Force report. The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, antiplatelet agents, adjunctive therapies (hydroxychloroquine, statins and vitamin D), targeted treatment including rituximab, belimumab, and anti-TNF agents, complement inhibition and drugs based on peptides of beta-2-glycoprotein I. In addition, the report summarises potential new players, including coenzyme Q10, adenosine receptor agonists and adenosine potentiation. In each case, the report provides recommendations for clinicians, based on the current state of the art, and suggests a clinical research agenda. The initiation and development of appropriate clinical studies requires a focus on devising suitable outcome measures, including a disease activity index, an optimal damage index, and a specific quality of life index.<\/jats:p>","DOI":"10.1177\/0961203320950461","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:09:43Z","timestamp":1603670983000},"page":"1571-1593","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":131,"title":["16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-390X","authenticated-orcid":false,"given":"Hannah","family":"Cohen","sequence":"first","affiliation":[{"name":"Haemostasis Research Unit, Department of Haematology, University College London, London, UK"},{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Cuadrado","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Clinica Universidad de Navarra, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[{"name":"Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-5719","authenticated-orcid":false,"given":"Ali","family":"Duarte-Garcia","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-2455","authenticated-orcid":false,"given":"David A","family":"Isenberg","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"Centre for Rheumatology, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S","family":"Knight","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Ortel","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, and Department of Pathology, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E","family":"Salmon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital for Special surgery, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-0975","authenticated-orcid":false,"given":"Maria G","family":"Tektonidou","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Williams","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"UCL EGA Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Willis","sequence":"additional","affiliation":[{"name":"Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-2705","authenticated-orcid":false,"given":"Scott C","family":"Woller","sequence":"additional","affiliation":[{"name":"Department of Medicine, Intermountain Medical Center, Murray UT; Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danieli","family":"Andrade","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,10,25]]},"reference":[{"key":"bibr1-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"bibr2-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.40901"},{"key":"bibr3-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187"},{"key":"bibr4-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.05.007"},{"key":"bibr5-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.053"},{"key":"bibr6-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-55442-6_18"},{"key":"bibr7-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.103"},{"key":"bibr8-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-011-0017-9"},{"key":"bibr9-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400509"},{"key":"bibr10-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02193.x"},{"key":"bibr11-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-08-0554"},{"key":"bibr12-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13475"},{"key":"bibr13-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.39938"},{"key":"bibr14-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu445cr"},{"key":"bibr15-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08753.x"},{"key":"bibr16-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213"},{"key":"bibr17-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30079-5"},{"key":"bibr18-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848333"},{"key":"bibr19-0961203320950461","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0291"},{"key":"bibr20-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/1076029615615960"},{"key":"bibr21-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/1076029617729214"},{"key":"bibr22-0961203320950461","first-page":"204","volume":"2","author":"Legault K","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"bibr23-0961203320950461","doi-asserted-by":"crossref","unstructured":"Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.\n                      N Engl J Med\n                      2003; 349: 1133-1138.","DOI":"10.1056\/NEJMoa035241"},{"key":"bibr24-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01340.x"},{"key":"bibr25-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319889156"},{"key":"bibr26-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319881200"},{"key":"bibr27-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.06.015"},{"key":"bibr28-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.04.009"},{"key":"bibr29-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571232"},{"key":"bibr30-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X16668588"},{"key":"bibr31-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-805689"},{"key":"bibr32-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14720"},{"key":"bibr33-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1159\/000065217"},{"key":"bibr34-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.09.001"},{"key":"bibr35-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14846"},{"key":"bibr36-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12264"},{"key":"bibr37-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13094"},{"key":"bibr38-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1316-1"},{"key":"bibr39-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14674"},{"key":"bibr40-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000924"},{"key":"bibr41-0961203320950461","unstructured":"Pharmacovigilance Risk Assessment Committee (PRAC). EMA\/ PRAC\/219985\/2019, https:\/\/www.ema.europa.eu\/en\/documents\/ prac-recommendation\/prac-recommendations-signals-adopted-8- 11-april-2019-prac-meeting _en.pdf. 2019 (accessed 11 August 2020)."},{"key":"bibr42-0961203320950461","unstructured":"Eliquis 5 mg film-coated tablets film-coated tablets. Summary of Product Characteristics, http:\/\/www.medicines. org.uk\/emc\/medicine\/27220."},{"key":"bibr43-0961203320950461","unstructured":"Lixiana 60 mg Film-Coated Tablets. Summary of Product Characteristics, https:\/\/www.medicines.org.uk\/emc\/ medicine\/30506 (accessed 11 August 2020)."},{"key":"bibr44-0961203320950461","unstructured":"Pradaxa 150 mg hard capsules. Summary of Product Characteristics, https:\/\/www.medicines.org.uk\/emc\/medic one\/24839 (accessed 11 August 2020)."},{"key":"bibr45-0961203320950461","unstructured":"Xarelto 15 and 20 mg film-coated tablets. Summary of Product Characteristics, https:\/\/www.medicines.org.uk\/emc\/medicine\/25586 (accessed 11 August 2020)."},{"key":"bibr46-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2300"},{"key":"bibr47-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep373"},{"key":"bibr48-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.10.014"},{"key":"bibr49-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.019"},{"key":"bibr50-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.22663"},{"key":"bibr51-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-381913"},{"key":"bibr52-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1311-6"},{"key":"bibr53-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312437440"},{"key":"bibr54-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0775-8"},{"key":"bibr55-0961203320950461","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2112"},{"key":"bibr56-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key307"},{"key":"bibr57-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.11.2245"},{"key":"bibr58-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.5.576"},{"key":"bibr59-0961203320950461","unstructured":"Boehringer-Ingelheim. Summary of product characteristics Persantin (dipyridamol) 100mg tablets. The electronic medicines compendium."},{"key":"bibr60-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613033"},{"key":"bibr61-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.12.006"},{"key":"bibr62-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-213520"},{"key":"bibr63-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8812-z"},{"key":"bibr64-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102491"},{"key":"bibr65-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.24232"},{"key":"bibr66-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317724219"},{"key":"bibr67-0961203320950461","doi-asserted-by":"crossref","unstructured":"Schmidt-Tanguy A, Voswinkel J, Henrion D, et\u00a0al. Anti-thrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.\n                      J Thromb Haemost\n                      August 2013; n\/a\u2013n\/a.","DOI":"10.1111\/jth.12363"},{"key":"bibr68-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.05.012"},{"key":"bibr69-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1160\/th15-06-0491"},{"key":"bibr70-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.09.078"},{"key":"bibr71-0961203320950461","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0037-1603359","volume":"43","author":"Schreiber K","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"bibr72-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308537"},{"key":"bibr73-0961203320950461","doi-asserted-by":"crossref","unstructured":"Taylor F, Huffman MD, et\u00a0al. Statins for the primary prevention of cardiovascular disease. Cochrane heart group, ed.\n                      Cochrane Database Syst Rev\n                      2013; Macedo AF. Published online January 31, doi:10.1002\/14651858.CD004816.pub5","DOI":"10.1002\/14651858.CD004816.pub5"},{"key":"bibr74-0961203320950461","doi-asserted-by":"publisher","DOI":"10.2174\/157016111106140128113121"},{"key":"bibr75-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900241"},{"key":"bibr76-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00896.x"},{"key":"bibr77-0961203320950461","doi-asserted-by":"crossref","unstructured":"Meroni PL, Raschi E, Testoni C, et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.\n                      Arthritis Rheum\n                      2001; 44(12): 2870-2878.","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y"},{"key":"bibr78-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203622"},{"key":"bibr79-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314541317"},{"key":"bibr80-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.04.009"},{"key":"bibr81-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.02.155"},{"key":"bibr82-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.05.005"},{"key":"bibr83-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2017.09.009"},{"key":"bibr84-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1035"},{"key":"bibr85-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86957"},{"key":"bibr86-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16013"},{"key":"bibr87-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.07.002"},{"key":"bibr88-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.134817"},{"key":"bibr89-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312446386"},{"key":"bibr90-0961203320950461","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2012.307"},{"key":"bibr91-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.007"},{"key":"bibr92-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318801520"},{"key":"bibr93-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603146"},{"key":"bibr94-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.03.011"},{"key":"bibr95-0961203320950461","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901812010248"},{"key":"bibr96-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0485-9"},{"key":"bibr97-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1096\/fj.15-272872"},{"key":"bibr98-0961203320950461","doi-asserted-by":"crossref","unstructured":"Beltowski J, Atanassova P, Chaldakov GN, Jamroz-Wisniewska A, Kula W, Rusek M. Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.\n                      Atherosclerosis\n                      2011 219: 526-531.","DOI":"10.1016\/j.atherosclerosis.2011.08.009"},{"key":"bibr99-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.6.7988455"},{"key":"bibr100-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0336"},{"key":"bibr101-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0718"},{"key":"bibr102-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det424"},{"key":"bibr103-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.4666"},{"key":"bibr104-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.0175"},{"key":"bibr105-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.15.1997"},{"key":"bibr106-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.27233"},{"key":"bibr107-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.34359"},{"key":"bibr108-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21664"},{"key":"bibr109-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"bibr110-0961203320950461","unstructured":"https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/07\/Rituximab-for-the-treatment-of-systemic-lupus-erythematosus-in-adults.pdf (accessed 7 March 2020)."},{"key":"bibr111-0961203320950461","doi-asserted-by":"crossref","unstructured":"Wang CR, Weng CT, Liu MF. Monocentric experience of the rituximab therapy in systemic lupus erythematosus-associated antiphospholipid syndrome with warfarin therapy failure.\n                      Semin Arthritis Rheum\n                      2017; 47: e7-e8.","DOI":"10.1016\/j.semarthrit.2017.03.012"},{"key":"bibr112-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700532"},{"key":"bibr113-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31818f38d4"},{"key":"bibr114-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.37759"},{"key":"bibr115-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078402"},{"key":"bibr116-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.946"},{"key":"bibr117-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1282599"},{"key":"bibr118-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22109"},{"key":"bibr119-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.10.013"},{"key":"bibr120-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omy072"},{"key":"bibr121-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2017.09.012"},{"key":"bibr122-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.05.004"},{"key":"bibr123-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318768890"},{"key":"bibr124-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-0928-z"},{"key":"bibr125-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2014.05.021"},{"key":"bibr126-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.11299"},{"key":"bibr127-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213496"},{"key":"bibr128-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.11.002"},{"key":"bibr129-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216367"},{"key":"bibr130-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316682102"},{"key":"bibr131-0961203320950461","doi-asserted-by":"crossref","unstructured":"Lockshin MD, Kim M, Laskin CA et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid syndrome.\n                      Arthritis and Rheumatism\n                      2012; 64: 2311-2318.","DOI":"10.1002\/art.34402"},{"key":"bibr132-0961203320950461","doi-asserted-by":"crossref","unstructured":"Kim MY, Buyon JP, Guerra MM, et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.\n                      Am J Obstet Gynecol\n                      2016; 214: 108.e1-108.e14.","DOI":"10.1016\/j.ajog.2015.09.066"},{"key":"bibr133-0961203320950461","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402220"},{"key":"bibr134-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.02.006"},{"key":"bibr135-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2244-0"},{"key":"bibr136-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232907"},{"key":"bibr137-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1571-4"},{"key":"bibr138-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0227-1"},{"key":"bibr139-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-019-0082-7"},{"key":"bibr140-0961203320950461","doi-asserted-by":"crossref","unstructured":"Pierangeli SS, Vega-Ostertag M, Liu X et al. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome.\n                      Ann N Y Acad Sci\n                      2005; 1051: 413-420.","DOI":"10.1196\/annals.1361.083"},{"key":"bibr141-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318817"},{"key":"bibr142-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031688"},{"key":"bibr143-0961203320950461","doi-asserted-by":"crossref","unstructured":"Salmon JE, Giradi G, Holers VM. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.\n                      Ann Rheum\n                      2002; 61(Suppl II): ii46-ii50.","DOI":"10.1136\/ard.61.suppl_2.ii46"},{"key":"bibr144-0961203320950461","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4794"},{"key":"bibr145-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-070631"},{"key":"bibr146-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2007.02.007"},{"key":"bibr147-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1038\/nm1121"},{"key":"bibr148-0961203320950461","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00773"},{"key":"bibr149-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2017.06.014"},{"key":"bibr150-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0910965"},{"key":"bibr151-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03696.x"},{"key":"bibr152-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.34440"},{"key":"bibr153-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12319"},{"key":"bibr154-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000267"},{"key":"bibr155-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000143"},{"key":"bibr156-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000290"},{"key":"bibr157-0961203320950461","first-page":"704371","volume":"2014","author":"Strakhan M","year":"2014","journal-title":"Case Rep Hematol"},{"key":"bibr158-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003863"},{"key":"bibr159-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014030228"},{"key":"bibr160-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006338"},{"key":"bibr161-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212224"},{"key":"bibr162-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502950"},{"key":"bibr163-0961203320950461","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030407"},{"key":"bibr164-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-001206"},{"key":"bibr165-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1191\/0961203306lu2315oa"},{"key":"bibr166-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.11.009"},{"key":"bibr167-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015345"},{"key":"bibr168-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-520882"},{"key":"bibr169-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13314"},{"key":"bibr170-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.22306"},{"key":"bibr171-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03316.x"},{"key":"bibr172-0961203320950461","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02413"},{"key":"bibr173-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309225"},{"key":"bibr174-0961203320950461","doi-asserted-by":"publisher","DOI":"10.2741\/4231"},{"key":"bibr175-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-400986"},{"key":"bibr176-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.39247"},{"key":"bibr177-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93897"},{"key":"bibr178-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/art.41057"},{"key":"bibr179-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02487-14"},{"key":"bibr180-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13373"},{"key":"bibr181-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09801-x"},{"key":"bibr182-0961203320950461","first-page":"2006","volume":"29","author":"Burcoglu-O\u2019Ral A","year":"2002","journal-title":"J Rheumatol"},{"key":"bibr183-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0145"},{"key":"bibr184-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.10.009"},{"key":"bibr185-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124804"},{"key":"bibr186-0961203320950461","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01322"},{"key":"bibr187-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14427"},{"key":"bibr188-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209442"},{"key":"bibr189-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102311"},{"key":"bibr190-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108265"},{"key":"bibr191-0961203320950461","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25680"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203320950461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0961203320950461","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203320950461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:22:49Z","timestamp":1777677769000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0961203320950461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":191,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1177\/0961203320950461"],"URL":"https:\/\/doi.org\/10.1177\/0961203320950461","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}